Ameriprise Financial Inc G1 Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.2 - $4.98 $1,320 - $2,988	-600 Reduced 1.69%	34,900 $79,000
Q4 2023 Feb 14, 2024	SELL	$1.12 - $3.73 $2,856 - $9,511	-2,550 Reduced 6.7%	35,500 $108,000
Q3 2023 Nov 14, 2023	SELL	$1.22 - $2.67 $108,987 - $238,521	-89,334 Reduced 70.13%	38,050 $54,000
Q2 2023 Aug 14, 2023	SELL	$2.46 - $3.14 $55,155 - $70,401	-22,421 Reduced 14.97%	127,384 $317,000
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $85,825 - $272,503	33,395 Added 28.69%	149,805 $401,000
Q4 2022 Feb 14, 2023	SELL	$5.19 - $13.5 $6,119 - $15,916	-1,179 Reduced 1.0%	116,410 $632,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $25,157 - $82,673	4,866 Added 4.32%	117,589 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $17,864 - $37,631	4,422 Added 4.08%	112,723 $557,000
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $59,660 - $86,507	7,850 Added 7.81%	108,301 $823,000
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $223,479 - $355,675	-21,996 Reduced 17.96%	100,451 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $89,435 - $152,706	6,796 Added 5.88%	122,447 $1.64 Million
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $827,576 - $1.11 Million	42,288 Added 57.64%	115,651 $2.54 Million
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $287,186 - $532,390	-16,336 Reduced 18.21%	73,363 $1.77 Million
Q4 2020 Feb 12, 2021	BUY	$10.99 - $20.4 $194,457 - $360,957	17,694 Added 24.57%	89,699 $1.61 Million
Q3 2020 Nov 16, 2020	SELL	$11.55 - $23.75 $80,295 - $165,110	-6,952 Reduced 8.8%	72,005 $832,000
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $91,527 - $233,074	-9,564 Reduced 10.8%	78,957 $1.92 Million
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $82,627 - $239,775	9,110 Added 11.47%	88,521 $976,000
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $232,348 - $350,672	11,312 Added 16.61%	79,411 $2.1 Million
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $201,899 - $359,660	-8,863 Reduced 11.52%	68,099 $1.55 Million
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $249,458 - $483,978	15,562 Added 25.35%	76,962 $2.36 Million
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $392,803 - $585,113	27,278 Added 79.94%	61,400 $1.02 Million
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $563,354 - $1.75 Million	34,122 New	34,122 $654,000
Q2 2018 Aug 14, 2018	SELL	$35.06 - $51.17 $1.08 Million - $1.57 Million	-30,769 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $586,149 - $1.28 Million	30,769 New	30,769 $1.14 Million

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account